{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:53:26Z","timestamp":1785556406819,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006315","name":"ReumaNederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022115","name":"Dutch Arthritis Association","doi-asserted-by":"publisher","award":["17-1-404"],"award-info":[{"award-number":["17-1-404"]}],"id":[{"id":"10.13039\/501100022115","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.joca.2022.09.014","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T15:49:53Z","timestamp":1669391393000},"page":"340-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["IL-1\u03b2 inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4513-8201","authenticated-orcid":false,"given":"Y.","family":"van Gemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.N.L.","family":"Kruisbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-5070","authenticated-orcid":false,"given":"A.B.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8074-826X","authenticated-orcid":false,"given":"M.H.J.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"van der Kraan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Pieterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-1596","authenticated-orcid":false,"given":"H.M.G.","family":"Princen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.E.M.","family":"van Lent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2022.09.014_bib1","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2022.09.014_bib2","first-page":"464","article-title":"Association between metabolic syndrome and knee osteoarthritis: a cross-sectional nationwide survey study","volume":"51","author":"Lee","year":"2019","journal-title":"J\u00a0Rehabil Med"},{"key":"10.1016\/j.joca.2022.09.014_bib3","doi-asserted-by":"crossref","first-page":"S827","DOI":"10.1016\/j.dsx.2017.07.002","article-title":"Relationship between metabolic syndrome and osteoarthritis: the Fasa Osteoarthritis Study","volume":"11","author":"Askari","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.joca.2022.09.014_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3810\/pgm.2009.11.2073","article-title":"Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data","volume":"121","author":"Puenpatom","year":"2009","journal-title":"Postgrad Med"},{"key":"10.1016\/j.joca.2022.09.014_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/00365513.2017.1354255","article-title":"Metabolic factors and oxidative stress in osteoarthritis: a case\u2013control study","volume":"77","author":"Tootsi","year":"2017","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.joca.2022.09.014_bib6","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1038\/s41598-018-23573-2","article-title":"Osteoarthritis-patterns, cardio-metabolic risk factors and risk of all-cause mortality: 20 years follow-up in patients after hip or knee replacement","volume":"8","author":"Buchele","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.joca.2022.09.014_bib7","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2016.03.48","article-title":"Metabolic syndrome and components exacerbate osteoarthritis symptoms of pain, depression and reduced knee function","volume":"4","author":"Li","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.joca.2022.09.014_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-03317-4","article-title":"Serum lipid levels and risk of hand osteoarthritis: the Chingford prospective cohort study","volume":"7","author":"Garc\u00eda-Gil","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.joca.2022.09.014_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/annrheumdis-2013-203248","article-title":"Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE\u22173Leiden.CETP mice--a translational model for atherosclerosis","volume":"73","author":"Gierman","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2022.09.014_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.joca.2016.07.020","article-title":"Synovial macrophages promote TGF-beta signaling and protect against influx of S100A8\/S100A9-producing cells after intra-articular injections of oxidized low-density lipoproteins","volume":"25","author":"de Munter","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.joca.2015.11.016","article-title":"High LDL levels lead to increased synovial inflammation and accelerated ectopic bone formation during experimental osteoarthritis","volume":"24","author":"de Munter","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4367","article-title":"Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis","volume":"15","author":"de Munter","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2022.09.014_bib13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1096\/fj.201600600r","article-title":"Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis","volume":"31","author":"Farnaghi","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.joca.2022.09.014_bib14","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.joca.2017.07.013","article-title":"Association between statin use and consultation or surgery for osteoarthritis of the hip or knee: a pooled analysis of four cohort studies","volume":"25","author":"Micha\u00eblsson","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib15","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/annrheumdis-2011-200092","article-title":"Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study","volume":"71","author":"Clockaerts","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2022.09.014_bib16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/acr.23735","article-title":"Statin use and knee osteoarthritis outcomes: a longitudinal cohort study","volume":"71","author":"Veronese","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.joca.2022.09.014_bib17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/ijms20030614","article-title":"The link between inflammaging and degenerative joint diseases","volume":"20","author":"Rezu\u0219","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joca.2022.09.014_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/289645","article-title":"Chronic inflammation in obesity and the metabolic syndrome","volume":"2010","author":"Monteiro","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.joca.2022.09.014_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-065X.2012.01151.x","article-title":"The inflammation highway: metabolism accelerates inflammatory traffic in obesity","volume":"249","author":"Johnson","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.joca.2022.09.014_bib20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.joca.2012.05.002","article-title":"Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage","volume":"20","author":"De Boer","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.joca.2006.10.010","article-title":"Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis","volume":"15","author":"Pearle","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.joca.2005.01.005","article-title":"Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis\u2013results of a 1 year longitudinal arthroscopic study in 422 patients","volume":"13","author":"Ayral","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/art.39438","article-title":"Brief report: association of inflammation with development of erosions in patients with hand osteoarthritis: a prospective ultrasonography study","volume":"68","author":"Kortekaas","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2022.09.014_bib24","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.11355","volume":"48","author":"Clements","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2022.09.014_bib25","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.40840","article-title":"A\u00a0phase II trial of lutikizumab, an anti\u2013interleukin-1\u03b1\/\u03b2 dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis","volume":"71","author":"Fleischmann","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2022.09.014_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3430","article-title":"A\u00a0randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee","volume":"13","author":"Cohen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2022.09.014_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.joca.2022.09.014_bib28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/M20-0527","article-title":"Effects of interleukin-1\u03b2 inhibition on incident hip and knee replacement: exploratory analyses from a randomized, double-blind, placebo-controlled trial","volume":"173","author":"Schieker","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joca.2022.09.014_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1194\/jlr.RA119000419","article-title":"Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice [S]","volume":"61","author":"Pouwer","year":"2020","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.joca.2022.09.014_bib30","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.joca.2021.02.570","article-title":"Novel high-intensive cholesterol-lowering therapies do not ameliorate knee OA development in humanized dyslipidemic mice","author":"van Gemert","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib31","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1194\/jlr.M053207","article-title":"PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE [S]","volume":"55","author":"Ason","year":"2014","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.joca.2022.09.014_bib32","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI118532","article-title":"Modulation of very low density lipoprotein production and clearance contributes to age-and gender-dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice","volume":"97","author":"Van Vlijmen","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joca.2022.09.014_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/dom.12252","article-title":"APOE\u2217 3Leiden. CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome","volume":"16","author":"van den Hoek","year":"2014","journal-title":"Diabetes Obes Metabol"},{"issue":"3","key":"10.1016\/j.joca.2022.09.014_bib34","first-page":"46","article-title":"Comment on \u201cHypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice\u201d by Rebholz SL et\u00a0al","author":"Princen","year":"2016","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.joca.2022.09.014_bib35","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","article-title":"Mouse models for atherosclerosis and pharmaceutical modifiers","volume":"27","author":"Zadelaar","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.joca.2022.09.014_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2015.03.089","article-title":"Innovative pharmaceutical interventions in cardiovascular disease: focusing on the contribution of non-HDL-C\/LDL-C-lowering versus HDL-C-raisingA systematic review and meta-analysis of relevant preclinical studies and clinical trials","volume":"763","author":"K\u00fchnast","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.joca.2022.09.014_bib37","article-title":"The APOE3-leiden heterozygous glucokinase knockout mouse as novel translational disease model for type 2 diabetes, dyslipidemia, and diabetic atherosclerosis","volume":"2019","author":"Pouwer","year":"2019","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.joca.2022.09.014_bib38","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.joca.2017.07.012","article-title":"WISP1\/CCN4 aggravates cartilage degeneration in experimental osteoarthritis","volume":"25","author":"Van den Bosch","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","article-title":"Osteoarthritis cartilage histopathology: grading and staging","volume":"14","author":"Pritzker","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib40","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1002\/art.23034","article-title":"Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor \u03b2\u2013induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation","volume":"56","author":"Davidson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2022.09.014_bib41","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.joca.2022.09.014_bib42","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2353\/ajpath.2007.061083","article-title":"Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage","volume":"171","author":"Fan","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joca.2022.09.014_bib43","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.joca.2015.02.167","article-title":"IL-1beta mediates MMP secretion and IL-1beta neosynthesis via upregulation of p22phox and NOX4 activity in human articular chondrocytes","volume":"23","author":"Rousset","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib44","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191430","article-title":"Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases","volume":"217","author":"Mailhot","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.joca.2022.09.014_bib45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.joca.2022.09.014_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/imr.12285","article-title":"NLRP3 at the interface of metabolism and inflammation","volume":"265","author":"Haneklaus","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.joca.2022.09.014_bib47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/annrheumdis-2018-213336","article-title":"Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1\u03b1 and anti-interleukin-1\u03b2 dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis","volume":"78","author":"Kloppenburg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2022.09.014_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.joca.2017.10.010","article-title":"Variable cartilage degradation in mice with diet-induced metabolic dysfunction: food for thought","volume":"26","author":"Kozijn","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib49","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.joca.2020.03.008","article-title":"High-fat feeding primes the mouse knee joint to develop osteoarthritis and pathologic infrapatellar fat pad changes after surgically induced injury","volume":"28","author":"Warmink","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.09.014_bib50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458422009323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458422009323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:58:47Z","timestamp":1761019127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458422009323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1063458422009323"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2022.09.014","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-1\u03b2 inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2022.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.","name":"copyright","label":"Copyright"}]}}